Cargando…
Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumors
BACKGROUND: Distant metastases frequently occur in gastroenteropancreatic neuroendocrine tumors. If hepatic surgery is not feasible, patients are treated with somatostatin analogs. However, the underlying mechanisms of action of this treatment remain to be defined. The aim of the present study was t...
Autores principales: | Bösch, Florian, Bazhin, Alexandr V., Heublein, Sabine, Brüwer, Katharina, Knösel, Thomas, Reiter, Florian P., Auernhammer, Christoph J., Guba, Markus O., Spitzweg, Christine, Werner, Jens, Angele, Martin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567424/ https://www.ncbi.nlm.nih.gov/pubmed/31196127 http://dx.doi.org/10.1186/s12885-019-5794-y |
Ejemplares similares
-
Distinct Expression Patterns of VEGFR 1-3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Supporting Clinical Relevance, but not a Prognostic Factor
por: Bösch, Florian, et al.
Publicado: (2020) -
Immuno-histochemical correlation of fibrosis-related markers with the desmoplastic reaction of the mesentery in small intestine neuroendocrine neoplasms
por: Bösch, Florian, et al.
Publicado: (2022) -
Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [(18)F]SiTATE
por: Eschbach, Ralf S., et al.
Publicado: (2023) -
Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
por: Machado-Alba, J. E., et al.
Publicado: (2022) -
A novel immune-related gene signature predicting survival in sarcoma patients
por: Ren, Haoyu, et al.
Publicado: (2021)